Skip to main content
Premium Trial:

Request an Annual Quote

Whistleblower Case Against NeoGenomics Dismissed

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NeoGenomics last week said that a whistleblower case filed against it and several healthcare companies last year has been voluntarily dismissed with prejudice by the plaintiff in the case.

As a result no further actions will be taken against the Ft. Myers, Fla.-based clinical reference lab, which focuses on cancer genetics diagnostic testing, it said.

On Nov. 9 2009, NeoGenomics was notified by the Civil Division of the US Department of Justice that a "qui tam" complaint had been filed against it and other companies, accusing them of "false or fraudulent claims and statements submitted or caused to be submitted by the defendants to Medicare," NeoGenomics said in a document filed with the US Securities and Exchange Commission on Nov. 23 2009.

The complaint sought damages and civil penalties, the company added.

In statement issued last week, NeoGenomics' Chairman and CEO Douglas VanOort said that the company was not surprised that the case was dismissed. "The plaintiff in this case should be ashamed of his actions and should be made to publicly apologize to the defendants and reimburse them for the legal expenses."

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.